Prithviraj Bose

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 65

Top Venues

American journal of hematology

Leukemia

Nature medicine

Blood

University of Texas MD Anderson Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas MD Anderson Cancer Center Feb 03 2015

United States

Assistant Professor :: Leukemia

Virginia Commonwealth University Jul 01 2010 - Jan 31 2015

United States

Assistant Professor :: Internal Medicine (Hematology/Oncology)

Publications

Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro Maria Maria Vannucchi, Rami S Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam J Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood advances 8 (17) (2024)
Steffen Koschmieder, Prithviraj Bose, Martin H Ellis, Vikas K Gupta, Jean-Jacques Kiladjian, John O Mascarenhas, Vikram Mathews, Francesco Passamonti, Claire Harrison
Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group. Leukemia 38 (8) (2024)
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro Maria Maria Vannucchi, Rami S Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam J Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood advances 8 (17) (2024)
Steffen Koschmieder, Prithviraj Bose, Martin H Ellis, Vikas K Gupta, Jean-Jacques Kiladjian, John O Mascarenhas, Vikram Mathews, Francesco Passamonti, Claire Harrison
Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group. Leukemia (2024)
Pankit Vachhani, Julian A Waksal, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K Rampal, Ruben Mesa, Srdan Verstovsek
Interferons in the treatment of myeloproliferative neoplasms. Therapeutic advances in hematology 15 (2024)
Chia-Yu Chiu, Teny M John, Takahiro Matsuo, Sebastian Wurster, Rachel S Hicklen, Raihaan Riaz Khattak, Ella J Ariza-Heredia, Prithviraj Bose, Dimitrios P Kontoyiannis
Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib: A Case Report and Review of the Literature on Ruxolitinib-Associated Invasive Fungal Infections. Journal of fungi (Basel, Switzerland) 10 (4) (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology 99 (7) (2024)
Aaron T Gerds, Claire N Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro Maria Maria Vannucchi, Rami S Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood advances (2024)
Steffen Koschmieder, Prithviraj Bose, Martin H Ellis, Vikas K Gupta, Jean-Jacques Kiladjian, John O Mascarenhas, Vikram Mathews, Francesco Passamonti, Claire Harrison
Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group. Leukemia 38 (8) (2024)
Ayalew Tefferi, Giovanni Barosi, Francesco Passamonti, Juan Carlos Carlos Hernández-Boluda, Prithviraj Bose, Konstanze Döhner, Martin Ellis, Naseema Gangat, Jacqueline S Garcia, Heinz Gisslinger, Jason Gotlib, Paola Guglielmelli, Vikas K Gupta, Claire N Harrison, Elizabeth O Hexner, Gabriela S Hobbs, Jean-Jacques Kiladjian, Steffen Koschmieder, Nicolaus M Kröger, Andrew T Kuykendall, Giuseppe Gaetano Loscocco, John O Mascarenhas, Lucia Masarova, Ruben A Mesa, Barbara Mora, Olatoyosi Odenike, Stephen T Oh, Animesh D Pardanani, Anand Ashwin Patel, Naveen Pemmaraju, Alessandro Rambaldi, Raajit K Rampal, Shireen Sirhan, Natasha Szuber, Moshe Talpaz, Pankit Vachhani, Alessandro M Vannucchi, Tiziano Barbui
Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis. Blood (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology 99 (7) (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology (2024)
Prithviraj Bose
Momelotinib for the treatment of myelofibrosis. Blood 144 (7) (2024)
Prithviraj Bose
Momelotinib for the treatment of myelofibrosis. Blood (2024)
Chia-Yu Chiu, Teny M John, Takahiro Matsuo, Sebastian Wurster, Rachel S Hicklen, Raihaan Riaz Khattak, Ella J Ariza-Heredia, Prithviraj Bose, Dimitrios P Kontoyiannis
Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib: A Case Report and Review of the Literature on Ruxolitinib-Associated Invasive Fungal Infections. Journal of fungi (Basel, Switzerland) 10 (4) (2024)
Steffen Koschmieder, Prithviraj Bose, Martin H Ellis, Vikas K Gupta, Jean-Jacques Kiladjian, John O Mascarenhas, Vikram Mathews, Francesco Passamonti, Claire Harrison
Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group. Leukemia 38 (8) (2024)
Chia-Yu Chiu, Teny M John, Takahiro Matsuo, Sebastian Wurster, Rachel S Hicklen, Raihaan Riaz Khattak, Ella J Ariza-Heredia, Prithviraj Bose, Dimitrios P Kontoyiannis
Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib: A Case Report and Review of the Literature on Ruxolitinib-Associated Invasive Fungal Infections. Journal of fungi (Basel, Switzerland) 10 (4) (2024)
Steffen Koschmieder, Prithviraj Bose, Martin H Ellis, Vikas K Gupta, Jean-Jacques Kiladjian, John O Mascarenhas, Vikram Mathews, Francesco Passamonti, Claire Harrison
Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group. Leukemia 38 (8) (2024)
Pankit Vachhani, Julian A Waksal, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K Rampal, Ruben Mesa, Srdan Verstovsek
Interferons in the treatment of myeloproliferative neoplasms. Therapeutic advances in hematology 15 (2024)
Pankit Vachhani, Julian A Waksal, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K Rampal, Ruben Mesa, Srdan Verstovsek
Interferons in the treatment of myeloproliferative neoplasms. Therapeutic advances in hematology 15 (2024)
Tapan Mahendra Kadia, Farhad Ravandi, Matteo Molica, Alex Bataller, Gautam Borthakur, Naval G Daver, Elias J Jabbour, Courtney D D DiNardo, Naveen Pemmaraju, Nitin Jain, Alessandra Ferrajoli, Musa Ylimaz, Prithviraj Bose, Rebecca S Slack Tidwell, Kayleigh R Marx, Caitlin R Rausch, Rashmi Kanagal-Shamana, Sa A Wang, Rabiul Islam, Richard Champlin, Elizabeth Shpall, Marina Y Konopleva, Guillermo Garcia Manero, Hagop M Kantarjian
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. American journal of hematology (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine (2023)
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Yawa Duose, Rebecca S Slack Tidwell, Nicholas James Short, Gautam Borthakur, Tapan Mahendra Kadia, Lucia Masarova, George D Tippett, Prithviraj Bose, Elias J Jabbour, Farhad Ravandi, Naval G Daver, Guillermo Garcia Manero, Hagop M Kantarjian, Jacqueline S Garcia, Paresh Vyas, Koichi Takahashi, Marina Y Konopleva, Courtney D D DiNardo
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies. Blood cancer discovery (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Jan Philipp Bewersdorf, Joan How, Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, John O Mascarenhas, Raajit K Rampal
Moving towards disease modification in polycythemia vera. Blood (2023)
Phillip A Thompson, Michael J Keating, Alessandra Ferrajoli, Nitin Jain, Christine B Peterson, Naveen Garg, Sa A Wang, Jeffrey L Jorgensen, Tapan Mahendra Kadia, Prithviraj Bose, Naveen Pemmaraju, Nicholas James Short, William G Wierda
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD. Leukemia (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Helen T Chifotides, Srdan Verstovsek, Prithviraj Bose
Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments. Cancers 15 (13) (2023)
Stephen T Oh, Ruben A Mesa, Claire N Harrison, Prithviraj Bose, Aaron T Gerds, Vikas K Gupta, Bart L Scott, Jean-Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah A Buckley, Shanthakumar Tyavanagimatt, Bryan G Harder, Karisse Roman-Torres, Jennifer Smith, Adam R Craig, John O Mascarenhas, Srdan Verstovsek
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis. Blood advances (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine (2023)
Pankit Vachhani, Srdan Verstovsek, Prithviraj Bose
Disease Modification in Myelofibrosis: An Elusive Goal? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (11) (2022)
Jayastu Senapati, Srdan Verstovsek, Lucia Masarova, Naveen Pemmaraju, Keyur P Patel, Guillermo Montalban-Bravo, Sherry A Pierce, Lingsha Zhou, Guillermo Garcia-Manero, Hagop M Kantarjian, Prithviraj Bose
Impact of SF3B1 mutation in myelofibrosis. Leukemia & lymphoma 63 (11) (2022)
Uri Rozovski, Ivo Veletic, David M Harris, Ping Li, Zhiming Liu, Preetesh Jain, Taghi Manshouri, Alessandra Ferrajoli, Jan A Burger, Prithviraj Bose, Phillip A Thompson, Nitin Jain, William G Wierda, Srdan Verstovsek, Michael J Keating, Zeev E Estrov
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells. Journal of immunology (Baltimore, Md. : 1950) 208 (12) (2022)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Jeffrey Skinner, Sara Dellasala, Musa Ylimaz, Alessandra Ferrajoli, Prithviraj Bose, Philip Thompson, Yesid Alvarado, Nitin Jain, Guillermo Garcia Manero, Koichi Takahashi, Gautam Borthakur, Naveen Pemmaraju, Sherry Pierce, Hagop M Kantarjian
Low-dose dasatinib 50 mg/day versus standard-dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis. American journal of hematology 97 (11) (2022)
Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, Naval G Daver, Koiji Sasaki, Helen T Chifotides, Lingsha Zhou, Hagop M Kantarjian, Zeev E Estrov, Srdan Verstovsek
Improved survival of patients with myelofibrosis in the last decade: Single-center experience. Cancer 128 (8) (2022)
Helen T Chifotides, Prithviraj Bose, Srdan Verstovsek
Momelotinib: an emerging treatment for myelofibrosis patients with anemia. Journal of hematology & oncology 15 (1) (2022)
Alexandra R Lovell, Nadya Jammal, Prithviraj Bose
Selecting the optimal BTK inhibitor therapy in CLL: rationale and practical considerations. Therapeutic advances in hematology 13 (2022)
Warren C Fiskus, Taghi Manshouri, Christine Birdwell, Christopher P Mill, Lucia Masarova, Prithviraj Bose, Tapan Mahendra Kadia, Naval G Daver, Courtney D D DiNardo, Gautam Borthakur, Joseph D Khoury, Srdan Verstovsek, Kapil N Bhalla
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells. Blood cancer journal 12 (1) (2022)
Prithviraj Bose, Srdan Verstovsek
Avapritinib for Systemic Mastocytosis. Expert review of hematology 14 (8) (2021)
Warren C Fiskus, Christopher P Mill, Behnam Nabet, Dimuthu Perera, Christine Birdwell, Taghi Manshouri, Bernardo Lara, Tapan Mahendra Kadia, Courtney D D DiNardo, Koichi Takahashi, Naval G Daver, Prithviraj Bose, Lucia Masarova, Naveen Pemmaraju, Steven Mitchell Kornblau, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Sunil Sharma, Matthew Stubbs, Xiaoping Su, Michael R Green, Cristian Coarfa, Srdan Verstovsek, Joseph D Khoury, Christopher R Vakoc, Kapil N Bhalla
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells. Blood cancer journal 11 (5) (2021)
Prithviraj Bose, Ruben A Mesa
Novel strategies for challenging scenarios encountered in managing myelofibrosis. Leukemia & lymphoma (2021)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Faezeh Darbaniyan, Maria Tariq Siddiqui, Koiji Sasaki, Yue Wei, Hui Yang, Kelly Sharon Chien, Kiran Naqvi, Elias J Jabbour, Tapan Mahendra Kadia, Naval G Daver, Courtney D D DiNardo, Farhad Ravandi, Naveen Pemmaraju, Prithviraj Bose, Srdan Verstovsek, Sherry Pierce, Carlos Bueso-Ramos, Keyur Patel, Kim-Anh Do, Hagop M Kantarjian, Guillermo Garcia Manero
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS). American journal of hematology 96 (7) (2021)
Abhishek Maiti, Courtney D D DiNardo, Naval G Daver, Caitlin R Rausch, Farhad Ravandi, Tapan Mahendra Kadia, Naveen Pemmaraju, Gautam Borthakur, Prithviraj Bose, Ghayas C Issa, Nicholas James Short, Musa Yilmaz, Guillermo Montalban-Bravo, Alessandra Ferrajoli, Elias J Jabbour, Nitin Jain, Maro Ohanian, Koichi Takahashi, Phillip A Thompson, Sanam Loghavi, Kathryn S Montalbano, Sherry Pierce, William G Wierda, Hagop M Kantarjian, Marina Y Konopleva
Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia. Blood cancer journal 11 (2) (2021)
Jason Gotlib, Andreas Reiter, Deepti H Radia, Michael W Deininger, Tracy I George, Jens Panse, Alessandro M Vannucchi, Uwe Platzbecker, Iván Alvarez-Twose, Andrzej Mital, Olivier Hermine, Ingunn Dybedal, Elizabeth O Hexner, Lisa K Hicks, Lambert Span, Ruben Mesa, Prithviraj Bose, Kristen M Pettit, Mark L Heaney, Stephen T Oh, Jayita Sen, Hui-Min Lin, Brenton G Mar, Daniel J DeAngelo
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial. Nature medicine (2021)
Nitin Jain, Phillip A Thompson, Jan A Burger, Alessandra Ferrajoli, Koichi Takahashi, Zeev E Estrov, Gautam Borthakur, Prithviraj Bose, Tapan Mahendra Kadia, Naveen Pemmaraju, Koiji Sasaki, Marina Y Konopleva, Elias J Jabbour, Naveen Garg, Xuemei Wang, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Wei Wang, Jeffrey Jorgensen, Sa Wang, Wanda Lopez, Ana Ayala, William Plunkett, Varsha Gandhi, Hagop M Kantarjian, Susan O'Brien, Michael Keating, William G Wierda
Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia 35 (12) (2021)
Daniel J DeAngelo, Deepti H Radia, Tracy I George, William A Robinson, Albert T Quiery, Mark W Drummond, Prithviraj Bose, Elizabeth O Hexner, Elliott F Winton, Hans-Peter Horny, Meera Tugnait, Oleg Schmidt-Kittler, Erica K Evans, Hui-Min Lin, Brenton G Mar, Srdan Verstovsek, Michael W Deininger, Jason Gotlib
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial. Nature medicine (2021)
Abhishek Maiti, Wei Qiao, Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Elias J Jabbour, Naval G Daver, Gautam Borthakur, Guillermo Garcia Manero, Sherry A Pierce, Kathryn S Montalbano, Naveen Pemmaraju, Kiran Naqvi, Maro Ohanian DO, Nicholas James Short, Yesid Alvarado, Koichi Takahashi, Musa Ylimaz, Nitin Jain, Steven M Kornblau, Michael Andreeff, Prithviraj Bose, Alessandra Ferrajoli, Ghayas C Issa, Lucia Masarova, Philip A Thompson, Caitlin R Rausch, Jing Ning, Hagop M Kantarjian, Courtney D D DiNardo, Marina Y Konopleva
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality. American journal of hematology 96 (3) (2020)
Prithviraj Bose, Srdan Verstovsek
Management of myelofibrosis after ruxolitinib failure. Leukemia & lymphoma 61 (8) (2020)
Bachar Samra, Guillaume Richard-Carpentier, Tapan M Kadia, Farhad Ravandi, Naval Daver, Courtney D D DiNardo, Ghayas C Issa, Prithviraj Bose, Marina Y Konopleva, Musa Yilmaz, Maro Ohanian, Gautam Borthakur, Guillermo Garcia-Manero, Sherry Pierce, Jorge E Cortes, Hagop Kantarjian, Nicholas J Short
Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype. Blood cancer journal 10 (5) (2020)
Helen T Chifotides, Prithviraj Bose, Srdan Verstovsek
Givinostat: an emerging treatment for polycythemia vera. Expert opinion on investigational drugs 29 (6) (2020)
Prithviraj Bose, Lucia Masarova, Srdan Verstovsek
Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms. Cancers 12 (10) (2020)
Prithviraj Bose, Srdan Verstovsek, Jorge E Cortes, Susan Tse, Yvonne Gasior, Nitin Jain, Elias J Jabbour, Zeev Estrov, Yesid Alvarado, Courtney D D DiNardo, Naveen Pemmaraju, Steven Mitchell Kornblau, Tapan Mahendra Kadia, Naval G Daver, Kiran Naqvi, Nicholas J Short, Lucia Masarova, John Villareal, Sherry A Pierce, Graciela Nogueras Gonzalez, Xuelin Huang, Guillermo Garcia-Manero, Hagop M Kantarjian, Farhad Ravandi
A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia. Leukemia 34 (9) (2020)
Beata Holkova, Danielle Shafer, Victor Yazbeck, Sandeep Dave, Prithviraj Bose, Mary Beth Tombes, Ellen Shrader, Wen Wan, Dipankar Bandyopadhyay, Caryn Weir, Elizabeth B Collins, Amanda Garnett, Maciej Kmieciak, John D Roberts, Guillermo Garcia-Manero, Steven Grant
Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome. Leukemia & lymphoma 62 (5) (2020)
Ghayas C Issa, Hagop M Kantarjian, Lianchun Xiao, Jing Ning, Yesid Alvarado, Gautam Borthakur, Naval Daver, Courtney D DiNardo, Elias Jabbour, Prithviraj Bose, Nitin Jain, Tapan Mahendra Kadia, Kiran Naqvi, Naveen Pemmaraju, Koichi Takahashi, Srdan Verstovsek, Micheal Andreeff, Steven Mitchell Kornblau, Zeev Estrov, Alessandra Ferrajoli, Guillermo Garcia-Manero, Maro Ohanian, William G Wierda, Farhad Ravandi, Jorge E Cortes
Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality. Leukemia 34 (11) (2020)
Uri Rozovski, David M Harris, Ping Li, Zhiming Liu, Preetesh Jain, Alessandra Ferrajoli, Jan A Burger, Prithviraj Bose, Phillip A Thompson, Nitin Jain, William G Wierda, Orit Uziel, Michael J Keating, Zeev E Estrov
STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage. Journal of immunology (Baltimore, Md. : 1950) 203 (11) (2019)
Prithviraj Bose, Lisa S Chen, Varsha Gandhi
Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the 'real world'. Leukemia & lymphoma 60 (7) (2019)
Musa Ylimaz, Hagop M Kantarjian, Xuemei Wang, Joseph D Khoury, Farhad Ravandi, Jeffrey Jorgensen, Nicholas James Short, Sanam Loghavi, Jorge E Cortes, Guillermo Garcia-Manero, Tapan Mahendra Kadia, Koji Sasaki, Marina Konopleva, Koichi Takahashi, William Wierda, Nitin Jain, Srdan Verstovsek, Zeev Estrov, Prithviraj Bose, Sherry Pierce, Rebecca Garris, Susan M O'Brien, Elias J Jabbour
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival. American journal of hematology 95 (2) (2019)
Prithviraj Bose, Mahesh Swaminathan, Naveen Pemmaraju, Alessandra Ferrajoli, Elias J Jabbour, Naval G Daver, Courtney D DiNardo, Yesid Alvarado, Musa Yilmaz, Julie Huynh-Lu, Wei Qiao, Xuemei Wang, Aurelio Matamoros, Lingsha Zhou, Sherry Pierce, Kurt D Schroeder, Hagop M Kantarjian, Srdan Verstovsek
A phase 2 study of pracinostat combined with ruxolitinib in patients with myelofibrosis. Leukemia & lymphoma 60 (7) (2019)
Fevzi F Yalniz, Imane Abou Dalle, Hagop M Kantarjian, Gautam Borthakur, Tapan Mahendra Kadia, Keyur Patel, Sanam Loghavi, Guillermo Garcia-Manero, Koji Sasaki, Naval G Daver, Courtney D D DiNardo, Naveen Pemmaraju, Nicholas James Short, Musa Ylimaz, Prithviraj Bose, Kiran Naqvi, Sherry Pierce, Graciela M Nogueras González, Marina Konopleva, Michael Andreeff, Jorge E Cortes, Farhad Ravandi
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib. American journal of hematology 94 (9) (2019)
Prithviraj Bose, Srdan Verstovsek
Updates in the management of polycythemia vera and essential thrombocythemia. Therapeutic advances in hematology 10 (2019)
Nicholas James Short, Elias J Jabbour, Kiran Naqvi, Ami Patel, Jing Ning, Koji Sasaki, Graciela M Nogueras-Gonzalez, Prithviraj Bose, Steven M Kornblau, Koichi Takahashi, Michael Andreeff, Gabriela Sanchez-Petitto, Zeev Estrov, Courtney D D DiNardo, Guillermo Montalban-Bravo, Marina Konopleva, Yesid Alvarado, Kapil N Bhalla, Warren Fiskus, Maria Khouri, Rubiul Islam, Hagop M Kantarjian, Guillermo Garcia-Manero
A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents. American journal of hematology 94 (1) (2018)
Prithviraj Bose, Aziz Nazha, Rami S Komrokji, Keyur P Patel, Sherry A Pierce, Najla Al-Ali, Andrew Sochacki, Aaron Shaver, Wencai Ma, Xiaoping Su, Naval G Daver, Courtney D DiNardo, Guillermo Garcia-Manero, Sanam Loghavi, Carlos Bueso-Ramos, Hagop M Kantarjian, Mikkael A Sekeres, Michael R Savona, Jaroslaw P Maciejewski, Srdan Verstovsek
Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable. Blood 132 (19) (2018)
Prithviraj Bose, Marina Y Konopleva
T-PLL: another check on the venetoclax list? Blood 130 (23) (2018)
Prithviraj Bose, Srdan Verstovsek
JAK2 inhibitors for myeloproliferative neoplasms: what is next? Blood 130 (2) (2017)

Prithviraj Bose.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Prithviraj Bose